Successful combined partial auxiliary liver and kidney transplantation in highly sensitized cross-match positive recipients

Am J Transplant. 2007 Jan;7(1):130-6. doi: 10.1111/j.1600-6143.2006.01592.x.

Abstract

Combined liver and renal transplantations can be performed against a positive cross-match, indicating that the liver protects the kidney from the harmful HLA antibodies. This led us to the hypothesis that a partial auxiliary liver graft may have a similar protective effect when performed together with the kidney in highly sensitized patients. Seven patients, with broadly reacting HLA antibodies and positive crossmatches, were transplanted with a partial liver and a kidney from the same donor. In one of the cases a living donor was used. We performed lymphocytotoxic and flow cross-matches before and after the transplantation. Cross-matches turned negative after grafting in five of seven cases. The kidney function was excellent, without rejections, during the follow-up (24-60 months) in these patients. In two cases the cross-match remained positive after transplantation, one with a never-functioning renal graft and the other with an early graft failure, probably due to humoral rejection. A simultaneous transplantation of a partial auxiliary liver graft from the same donor, with the sole purpose of protecting the kidney from harmful lymphocytotoxic antibodies, can be performed successfully despite a positive cross-match and may thus be a new option of treatment for highly sensitized patients waiting for a kidney transplant.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antilymphocyte Serum
  • Female
  • Graft Survival
  • HLA Antigens / immunology*
  • Histocompatibility Testing
  • Humans
  • Isoantibodies
  • Kidney Diseases / therapy*
  • Kidney Transplantation / immunology
  • Kidney Transplantation / methods*
  • Liver Transplantation / immunology*
  • Male
  • Middle Aged
  • Transplantation Immunology*
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • HLA Antigens
  • Isoantibodies